Toshimasa Aranami

Author PubWeight™ 12.32^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	The regulatory role of natural killer cells in multiple sclerosis.	Brain	2004	1.84
2	Cutting edge: Human Th17 cells are identified as bearing CCR2+CCR5- phenotype.	J Immunol	2007	1.77
3	Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study.	Neurology	2014	1.62
4	Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.	Proc Natl Acad Sci U S A	2011	1.60
5	Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab.	Mod Rheumatol	2012	1.17
6	T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients.	J Neuroimmunol	2006	1.13
7	Plasmablasts as migratory IgG-producing cells in the pathogenesis of neuromyelitis optica.	PLoS One	2013	0.89
8	Tumour necrosis factor-alpha but not lipopolysaccharide enhances preference of murine dendritic cells for Th2 differentiation.	Immunology	2003	0.86
9	CCR2(+)CCR5(+) T cells produce matrix metalloproteinase-9 and osteopontin in the pathogenesis of multiple sclerosis.	J Immunol	2012	0.86
10	Positive and negative selection of T cell repertoires during differentiation in allogeneic bone marrow chimeras.	Transpl Immunol	2003	0.77
11	Increase of Ki-67+ natural killer cells in multiple sclerosis patients treated with interferon-β and interferon-β combined with low-dose oral steroids.	J Neuroimmunol	2011	0.75